SK Inc. announces First-Ever ‘Value-Up’ Plan Among Korean Holding Companies…
SK Inc. announced plans to enhance the stability and scale of shareholder returns, targeting corporate value growth through portfolio rebalancing, strengthening financial resilience, and improving operational efficiency.
SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023
- With a dedicated booth in the main exhibition hall, SK pharmteco solidifies its global position as the most trusted CDMO partner in the pharmaceutical industry
- Appoints Chief Commercial Officer Andrew Fenny to strengthen its global marketing capabilities
- Shortlisted as a finalist for the 2023 CPHI Pharma Awards in the Accelerating Innovation category
SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in CBM
-CBM brings extensive cell and gene therapy expertise to SK pharmteco portfolio and continues SK pharmteco’s strategy to deliver end-to-end, multi-modality support for clients
-SK pharmteco previously invested $350 million in CBM in 2022
SK Inc.’s board of directors declares an interim dividend of KRW 1,500 per share
- The first interim dividend payout after Articles of Incorporation were amended to enable investors to invest after checking dividend amount
- Shareholders of record as of August 10, 2023 will receive dividend payout
SK pharmteco doubles viral vector production capacity in Europe
Yposkesi, SK pharmteco’s clinical and commercial viral vector manufacturing subsidiary for Cell and Gene Therapy, completes its second bioproduction facility and doubles its manufacturing footprint to 10,000m2, one of the largest in Europe
- Operation of the second facility to kick start in 2024
SK Inc.-SK innovation-Korea Hydro & Nuclear Power Sign MOU to Cooperate in Clean Energy Business
- Enhancing collaborative business efforts in clean energy including nuclear power, renewable energy, hydrogen and SMR, for a sustainable future
- Achieving carbon neutrality through global competiveness in sustainable energy
SK Inc.’s subsidiary Yes Power Technix renames itself to SK powertech
-Renaming reflects the company’s drive to accelerate competitiveness in SiC power semiconductor design and manufacturing after the 2022 acquisition by SK Inc.
-New plant in Busan City to kick-start commercial production in April
SK Inc. to bolster its investment in future mobility in the fast growing Southeast Asian market
SK Inc., the strategic investment holding company of South Korea’s SK Group, announced on Thursday that it has agreed to sell its entire stake in Turo, a peer-to-peer (P2P) vehicle car-sharing company, for USD 67.5 million (approximately KRW 88.1 billion). The transaction is expected to be completed in the first half of this year with SK Inc. selling its stake in Turo to existing shareholder G Squared.
SK Inc. hosts “SK Bio Night” in San Francisco to expand global partnerships
-SK to spark innovative ideas and identify new business opportunities by presenting its global strategy and growth roadmap to over 50 partners
-Newly appointed executives to lead SK’s biopharmaceutical businesses to attend the event
-SK Inc. to promote the competitiveness of K-bio and provide insight into its remarkable achievements in the US, Europe and Korea markets
SK Inc. Showcases Technologies That Will Lead to a Carbon Neutral Future at CES 2023
- SK Inc. introduces its net zero value chain, including eco-friendly, energy-saving technologies that target carbon reduction
- SK Signet, Atom Power, Halio, Perfect Day Inc., and other companies in SK Inc.’s investment portfolio demonstrate key solutions to achieving net zero emissions
- To help realize a net zero future, SK will also operate a ‘Sustainable Food Truck’ at CES 2023 that will provide animal-free whey protein food
SK Inc. receives the highest ESG rating of ‘AAA’ from MSCI
- The company has been selected for the DJSI World Index for the 11th consecutive year with highest score in the Industrial Conglomerates Industry category
- SK Inc. also receives A+ for the third consecutive year from the Korea Institute of Corporate Governance and Sustainability
SK Inc. diversifies its sustainable food business, strengthening global and local partnerships
- SK Inc. invests $7 million (KRW 10 billion) in the U.S-based cell-cultivated salmon producer Wildtype expecting commercialization in 2023
- SK Inc., Perfect Day and Maeil Dairies sign an MOU to propel non-animal dairy protein business in Korea
- Aju IB Investment endorses the growth potential of Meatless Farm with a $7 million (KRW 10 billion) investment in the sustainable food producer in which SK Inc. has also invested in
SK Inc. announces share buyback worth 1% of market cap
- SK Inc. to buyback KRW200 billion worth of its own shares in the next 6 months, marking the first step to implement the shareholders return policy
- The share buyback/cancellation program intends to improve shareholder value and strengthen the market confidence
SK Inc. becomes second-largest shareholder of the Center for Breakthrough Medicines
SK Inc. becomes second-largest shareholder of the Center for Breakthrough Medicines, a U.S.-based Cell and Gene Therapy (CGT) CDMO, accelerating its growth as a global leader in the field
SK Inc. affiliate SK Pharmteco aims to become a top global CDMO with $2B in annual sales
- SK pharmteco presented at the J.P Morgan HealthCare Conference as the sole Korean company in the Private Track
- Aslam Malik, CEO of SK pharmteco presented major performance results and “Vision 2025” growth strategy
- SK pharmteco forecasts to see record-high sales of $740 million in 2021, growing 7.5 times since beginning its global expansion
- The company to establish a cycle of growth investing and foster new growth driver based on the stable sales of small molecule API business
- SK Inc. to land pre-IPO this year, materializing SK pharmteco’s IPO plan
